The store will not work correctly when cookies are disabled.
2,2-dimethyl-5-(4-(methylsulfonyl)phenyl)-4-m-tolylfuran-3(2H)-one
ID: ALA3975911
PubChem CID: 18386006
Max Phase: Preclinical
Molecular Formula: C20H20O4S
Molecular Weight: 356.44
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: Cc1cccc(C2=C(c3ccc(S(C)(=O)=O)cc3)OC(C)(C)C2=O)c1
Standard InChI: InChI=1S/C20H20O4S/c1-13-6-5-7-15(12-13)17-18(24-20(2,3)19(17)21)14-8-10-16(11-9-14)25(4,22)23/h5-12H,1-4H3
Standard InChI Key: FAKOKFQFCDOHKL-UHFFFAOYSA-N
Molfile:
RDKit 2D
25 27 0 0 0 0 0 0 0 0999 V2000
25.1465 -24.0330 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
24.9338 -24.8336 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
25.7335 -24.6175 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
27.6944 -29.4835 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.2858 -28.7704 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.8726 -29.4808 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.6210 -28.2860 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
27.9582 -28.2869 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.7022 -27.4992 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.8774 -27.5024 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.7428 -28.5440 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
26.3934 -26.8397 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.7303 -26.0846 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.2451 -25.4176 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.4230 -25.5042 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.0886 -26.2638 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.5758 -26.9278 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.1152 -24.9254 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.1830 -26.8310 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.0052 -26.9172 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.4891 -26.2490 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.1519 -25.4944 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.3259 -25.4119 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.8458 -26.0810 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.3104 -26.3341 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2 1 2 0
3 2 2 0
5 4 1 0
6 5 1 0
7 5 1 0
5 8 1 0
8 9 1 0
9 10 2 0
10 7 1 0
8 11 2 0
12 13 2 0
13 14 1 0
14 15 2 0
15 16 1 0
16 17 2 0
17 12 1 0
10 12 1 0
15 2 1 0
2 18 1 0
19 20 2 0
20 21 1 0
21 22 2 0
22 23 1 0
23 24 2 0
24 19 1 0
9 19 1 0
21 25 1 0
M END
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 356.44 | Molecular Weight (Monoisotopic): 356.1082 | AlogP: 3.64 | #Rotatable Bonds: 3 |
Polar Surface Area: 60.44 | Molecular Species: NEUTRAL | HBA: 4 | HBD: ┄ |
#RO5 Violations: ┄ | HBA (Lipinski): 4 | HBD (Lipinski): ┄ | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: ┄ | CX Basic pKa: ┄ | CX LogP: 3.55 | CX LogD: 3.55 |
Aromatic Rings: 2 | Heavy Atoms: 25 | QED Weighted: 0.84 | Np Likeness Score: -0.25 |
References
1. (2002) 4,5-diaryl-3(2H)-furanone derivatives as cyclooxygenase-2 inhibitors, |